Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Elliot

Showing results (191-200 of 406) with videos related to

Pageof 41
Sort By:
Pulmonary Circulation|May 5, 2012
Serum osteoprotegerin is increased and predicts survival in idiopathic pulmonary arterial hypertensionRobin Condliffe, Josephine A Pickworth, Kay Hopkinson, et al.
The Lancet. Respiratory Medicine|June 19, 2017
Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort studyChristopher J Rhodes, John Wharton, Pavandeep Ghataorhe, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 11, 2024
The spectrum of systemic sclerosis-associated pulmonary hypertension: Insights from the ASPIRE registryHoward Smith, A A Roger Thompson, Mohammed Akil, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2014
Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumoniaTamera J Corte, Gregory J Keir, Konstantinos Dimopoulos, et al.
Pulmonary Circulation|April 19, 2019
The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE RegistryCatherine G Billings, Robert Lewis, Judith A Hurdman, et al.
ERJ Open Research|March 25, 2026
Diffusing capacity of the lung for carbon monoxide, transfer coefficient of the lung for carbon monoxide and forced vital capacity/diffusing capacity of the lung for carbon monoxide in suspected systemic sclerosis-associated pulmonary hypertension: insights from the ASPIRE registryHoward Smith, A A Roger Thompson, Mohammed Akil, et al.
Pulmonary Circulation|April 15, 2020
Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype?Andrew J Peacock, Yi Ling, Martin K Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2012
Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and IrelandYi Ling, Martin K Johnson, David G Kiely, et al.
American Journal of Respiratory and Critical Care Medicine|December 11, 2012
Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertensionChristopher J Rhodes, John Wharton, Reinier A Boon, et al.
Respirology (Carlton, Vic.)|April 7, 2020
Partial anomalous pulmonary venous drainage in patients presenting with suspected pulmonary hypertension: A series of 90 patients from the ASPIRE registryRobert A Lewis, Catherine G Billings, Aidan Bolger, et al.
Pageof 41

Showing results (191-200 of 406) with videos related to

Sort By:
Pageof 41
Pulmonary Circulation|May 5, 2012
Serum osteoprotegerin is increased and predicts survival in idiopathic pulmonary arterial hypertensionRobin Condliffe, Josephine A Pickworth, Kay Hopkinson, et al.
The Lancet. Respiratory Medicine|June 19, 2017
Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort studyChristopher J Rhodes, John Wharton, Pavandeep Ghataorhe, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 11, 2024
The spectrum of systemic sclerosis-associated pulmonary hypertension: Insights from the ASPIRE registryHoward Smith, A A Roger Thompson, Mohammed Akil, et al.
American Journal of Respiratory and Critical Care Medicine|June 18, 2014
Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumoniaTamera J Corte, Gregory J Keir, Konstantinos Dimopoulos, et al.
Pulmonary Circulation|April 19, 2019
The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE RegistryCatherine G Billings, Robert Lewis, Judith A Hurdman, et al.
ERJ Open Research|March 25, 2026
Diffusing capacity of the lung for carbon monoxide, transfer coefficient of the lung for carbon monoxide and forced vital capacity/diffusing capacity of the lung for carbon monoxide in suspected systemic sclerosis-associated pulmonary hypertension: insights from the ASPIRE registryHoward Smith, A A Roger Thompson, Mohammed Akil, et al.
Pulmonary Circulation|April 15, 2020
Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype?Andrew J Peacock, Yi Ling, Martin K Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2012
Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and IrelandYi Ling, Martin K Johnson, David G Kiely, et al.
American Journal of Respiratory and Critical Care Medicine|December 11, 2012
Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertensionChristopher J Rhodes, John Wharton, Reinier A Boon, et al.
Respirology (Carlton, Vic.)|April 7, 2020
Partial anomalous pulmonary venous drainage in patients presenting with suspected pulmonary hypertension: A series of 90 patients from the ASPIRE registryRobert A Lewis, Catherine G Billings, Aidan Bolger, et al.
Pageof 41